UBS AM’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $87.6M | Sell |
6,262,277
-504,639
| -7% | -$7.06M | 0.02% | 564 |
|
2025
Q1 | $92M | Buy |
6,766,916
+3,184,042
| +89% | +$43.3M | 0.02% | 564 |
|
2024
Q4 | $73M | Sell |
3,582,874
-166,612
| -4% | -$3.4M | 0.02% | 584 |
|
2024
Q3 | $109M | Buy |
3,749,486
+1,451,770
| +63% | +$42.3M | 0.03% | 495 |
|
2024
Q2 | $53.4M | Buy |
2,297,716
+1,610,477
| +234% | +$37.4M | 0.02% | 604 |
|
2024
Q1 | $14.1M | Sell |
687,239
-21,100
| -3% | -$433K | 0.01% | 898 |
|
2023
Q4 | $15.2M | Buy |
708,339
+65,039
| +10% | +$1.4M | 0.01% | 850 |
|
2023
Q3 | $13.3M | Buy |
643,300
+76,159
| +13% | +$1.57M | 0.01% | 860 |
|
2023
Q2 | $13.1M | Hold |
567,141
| – | – | 0.01% | 873 |
|
2023
Q1 | $13.1M | Buy |
567,141
+23,218
| +4% | +$535K | 0.01% | 873 |
|
2022
Q4 | $15.1M | Buy |
543,923
+13,719
| +3% | +$382K | 0.01% | 820 |
|
2022
Q3 | $16.3M | Buy |
530,204
+42,799
| +9% | +$1.31M | 0.01% | 815 |
|
2022
Q2 | $14.3M | Buy |
487,405
+52,578
| +12% | +$1.55M | 0.01% | 833 |
|
2022
Q1 | $14M | Sell |
434,827
-5,209
| -1% | -$168K | 0.01% | 945 |
|
2021
Q4 | $19.6M | Buy |
440,036
+5,302
| +1% | +$236K | 0.01% | 902 |
|
2021
Q3 | $21.9M | Buy |
434,734
+4,863
| +1% | +$245K | 0.01% | 840 |
|
2021
Q2 | $33.7M | Buy |
429,871
+131,587
| +44% | +$10.3M | 0.01% | 742 |
|
2021
Q1 | $17M | Sell |
298,284
-111,399
| -27% | -$6.36M | 0.01% | 902 |
|
2020
Q4 | $34.3M | Sell |
409,683
-85,224
| -17% | -$7.14M | 0.02% | 705 |
|
2020
Q3 | $17.7M | Buy |
494,907
+2,238
| +0.5% | +$80.2K | 0.01% | 806 |
|
2020
Q2 | $11.9M | Buy |
492,669
+426,528
| +645% | +$10.3M | 0.01% | 860 |
|
2020
Q1 | $1.16M | Buy |
66,141
+8,286
| +14% | +$145K | ﹤0.01% | 1638 |
|
2019
Q4 | $1.01M | Sell |
57,855
-2,017
| -3% | -$35.1K | ﹤0.01% | 1912 |
|
2019
Q3 | $917K | Buy |
59,872
+10,461
| +21% | +$160K | ﹤0.01% | 1998 |
|
2019
Q2 | $1.03M | Buy |
49,411
+19,666
| +66% | +$408K | ﹤0.01% | 1871 |
|
2019
Q1 | $691K | Buy |
29,745
+9,972
| +50% | +$232K | ﹤0.01% | 1971 |
|
2018
Q4 | $409K | Buy |
19,773
+5,073
| +35% | +$105K | ﹤0.01% | 2079 |
|
2018
Q3 | $320K | Buy |
+14,700
| New | +$320K | ﹤0.01% | 2256 |
|